Reckitt Benckiser Group Stock Performance
RBGPF Stock | USD 60.04 0.45 0.76% |
The company holds a Beta of -0.86, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Reckitt Benckiser are expected to decrease slowly. On the other hand, during market turmoil, Reckitt Benckiser is expected to outperform it slightly. At this point, Reckitt Benckiser has a negative expected return of -0.0198%. Please make sure to check Reckitt Benckiser's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Reckitt Benckiser performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Reckitt Benckiser Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Reckitt Benckiser is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 1.6 B | |
Total Cashflows From Investing Activities | 239 M |
Reckitt |
Reckitt Benckiser Relative Risk vs. Return Landscape
If you would invest 6,175 in Reckitt Benckiser Group on October 20, 2024 and sell it today you would lose (171.00) from holding Reckitt Benckiser Group or give up 2.77% of portfolio value over 90 days. Reckitt Benckiser Group is currently producing negative expected returns and takes up 2.3058% volatility of returns over 90 trading days. Put another way, 20% of traded pink sheets are less volatile than Reckitt, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Reckitt Benckiser Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Reckitt Benckiser's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Reckitt Benckiser Group, and traders can use it to determine the average amount a Reckitt Benckiser's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0086
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | RBGPF |
Estimated Market Risk
2.31 actual daily | 20 80% of assets are more volatile |
Expected Return
-0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Reckitt Benckiser is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reckitt Benckiser by adding Reckitt Benckiser to a well-diversified portfolio.
Reckitt Benckiser Fundamentals Growth
Reckitt Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Reckitt Benckiser, and Reckitt Benckiser fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Reckitt Pink Sheet performance.
Return On Equity | 0.39 | |||
Return On Asset | 0.0681 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 61.62 B | |||
Shares Outstanding | 715.77 M | |||
Price To Earning | 30.53 X | |||
Price To Book | 4.62 X | |||
Price To Sales | 3.75 X | |||
Revenue | 13.23 B | |||
EBITDA | 465 M | |||
Cash And Equivalents | 1.29 B | |||
Cash Per Share | 1.80 X | |||
Total Debt | 6.81 B | |||
Debt To Equity | 1.10 % | |||
Book Value Per Share | 12.47 X | |||
Cash Flow From Operations | 1.7 B | |||
Earnings Per Share | 5.15 X | |||
Total Asset | 26.95 B | |||
Retained Earnings | 21.09 B | |||
Current Asset | 3.48 B | |||
Current Liabilities | 6.07 B | |||
About Reckitt Benckiser Performance
By analyzing Reckitt Benckiser's fundamental ratios, stakeholders can gain valuable insights into Reckitt Benckiser's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Reckitt Benckiser has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Reckitt Benckiser has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company was founded in 1819 and is headquartered in Slough, the United Kingdom. Reckitt Benckiser operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 40000 people.Things to note about Reckitt Benckiser performance evaluation
Checking the ongoing alerts about Reckitt Benckiser for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Reckitt Benckiser help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Reckitt Benckiser generated a negative expected return over the last 90 days | |
Reckitt Benckiser Group has accumulated 6.81 B in total debt with debt to equity ratio (D/E) of 1.11, which is about average as compared to similar companies. Reckitt Benckiser has a current ratio of 0.69, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Reckitt Benckiser until it has trouble settling it off, either with new capital or with free cash flow. So, Reckitt Benckiser's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Reckitt Benckiser sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Reckitt to invest in growth at high rates of return. When we think about Reckitt Benckiser's use of debt, we should always consider it together with cash and equity. | |
The entity reported the revenue of 13.23 B. Net Loss for the year was (32 M) with profit before overhead, payroll, taxes, and interest of 7.69 B. | |
About 60.0% of Reckitt Benckiser shares are owned by institutional investors |
- Analyzing Reckitt Benckiser's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Reckitt Benckiser's stock is overvalued or undervalued compared to its peers.
- Examining Reckitt Benckiser's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Reckitt Benckiser's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Reckitt Benckiser's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Reckitt Benckiser's pink sheet. These opinions can provide insight into Reckitt Benckiser's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Reckitt Pink Sheet analysis
When running Reckitt Benckiser's price analysis, check to measure Reckitt Benckiser's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reckitt Benckiser is operating at the current time. Most of Reckitt Benckiser's value examination focuses on studying past and present price action to predict the probability of Reckitt Benckiser's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reckitt Benckiser's price. Additionally, you may evaluate how the addition of Reckitt Benckiser to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Managers Screen money managers from public funds and ETFs managed around the world |